Literature DB >> 9879341

Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels.

M Molls1, P Stadler, A Becker, H J Feldmann, J Dunst.   

Abstract

At the beginning of this century Schwarz (1909) and Holthusen (1921) observed the influence of oxygen on the radiosensitivity of cells. In 1951 Hollaender et al. described that E. coli needed 3-fold higher radiation doses when treated under anoxic conditions compared to normoxic conditions. This led to the evaluation of the oxygen enhancement ratio (OER) for photons (X-rays), neutrons and heavy ions. It was found that the OER for conventional radiation therapy (RT) with photons is much higher (about 3) than the OER for neutron-RT (only 1.5) or heavy ions. According to a hypothesis free radicals which are produced by radiation are fixed in the presence of oxygen. Radicals are interacting with DNA, macromolecules and membranes. The DNA lesion can be followed by cell death. There is some evidence that tumor cells respond to hypoxia with the expression of a variety of genes coding for oxygen regulated proteins such as c-jun, VEGF or p53. Hypoxia also enhances the genetic instability of tumor cells. Oxygen tensions in malignant tumors can be determined under clinical routine conditions by using a computerized polarographic needle electrode system (Eppendorf, Hamburg, Germany). Several studies in the past years showed that tumors are in general more hypoxic than the surrounding normal tissue and that a marked variability of intra- as well as intertumoral pO2 values exist (for review see Vaupel and Höckel 1998). Moreover, it has been shown in different tumor entities that the oxygenation status influences the local control rate and overall survival. Furthermore, the oxygenation status obtained at one site (primary) is significantly related at other sites (lymph node metastases) in patients with squamous cell carcinoma of the head and neck (SCCHN). In addition, there is a significant correlation between hemoglobin level and tumor oxygenation in patients with SCCHN. There is some evidence that the oxygenation status can be improved by the correction of a low hemoglobin level and consequently, the curative chance might rise.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879341

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  11 in total

1.  Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy.

Authors:  Davide Franceschini; Fabiola Paiar; Calogero Saieva; Pierluigi Bonomo; Benedetta Agresti; Icro Meattini; Daniela Greto; Monica Mangoni; Fiammetta Meacci; Mauro Loi; Giacomo Zei; Lorenzo Livi; Giampaolo Biti
Journal:  Radiol Med       Date:  2015-09-24       Impact factor: 3.469

2.  Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?

Authors:  T Auberger; B Thürriegl; T Freude; L Weissfloch; R Senekowitsch-Schmidke; P Kneschaurek; F M Wagner; M Molls
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

3.  High expression levels of erythropoietin and its receptor are not correlated with shorter survival in human glioblastoma.

Authors:  J Brunotte; H C Bock; W Brück; B Hemmerlein; H Strik
Journal:  Exp Ther Med       Date:  2011-01-19       Impact factor: 2.447

4.  Hypoxia and VEGF mRNA expression in human tumors.

Authors:  L S Ziemer; C J Koch; A Maity; D P Magarelli; A M Horan; S M Evans
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

5.  Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling.

Authors:  Justin B Maxhimer; David R Soto-Pantoja; Lisa A Ridnour; Hubert B Shih; William G Degraff; Maria Tsokos; David A Wink; Jeff S Isenberg; David D Roberts
Journal:  Sci Transl Med       Date:  2009-10-21       Impact factor: 17.956

6.  Three-dimensional alginate hydrogels for radiobiological and metabolic studies of cancer cells.

Authors:  Graham H Read; Natsuko Miura; Jenna L Carter; Kelsey T Kines; Kazutoshi Yamamoto; Nallathamby Devasahayam; Jason Y Cheng; Kevin A Camphausen; Murali C Krishna; Aparna H Kesarwala
Journal:  Colloids Surf B Biointerfaces       Date:  2018-06-18       Impact factor: 5.268

7.  Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer.

Authors:  Silas C Martin; Dennis D Gagnon; Lucy Zhang; Carsten Bokemeyer; Marinus Van Marwijk Kooy; Ben van Hout
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 8.  Management options for cancer therapy-related anaemia.

Authors:  Tim J Littlewood
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

9.  Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

Authors:  Florian C Maier; Manfred Kneilling; Gerald Reischl; Funda Cay; Daniel Bukala; Andreas Schmid; Martin S Judenhofer; Martin Röcken; Hans-Jürgen Machulla; Bernd J Pichler
Journal:  Radiat Oncol       Date:  2011-11-25       Impact factor: 3.481

Review 10.  Radiosensitization in prostate cancer: mechanisms and targets.

Authors:  Diego A Palacios; Makito Miyake; Charles J Rosser
Journal:  BMC Urol       Date:  2013-01-26       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.